Skip to main content
. 2021 May 13;28(3):1835–1846. doi: 10.3390/curroncol28030170
CCI Charlson co-morbidity index
CTCAE Common toxicity criteria for adverse events
DART Dose-differentiated accelerated radiotherapy
ECOG Eastern cooperative oncology group
EQD2 Biologically equivalent dose in 2 Gy fractions
IMRT Intensity modulated radiotherapy
LC Local control
mOS Median overall survival
MVA Multivariate analysis
NSCLC Non-small cell lung cancer
OAR Organs at risk
OS Overall survival
PS Performance score
RT Radiotherapy
SABR Stereotactic ablative body therapy
SCLC Small-cell lung cancer
UVA Univariate analysis
VMAT Volumetric intensity modulated arc therapy